X @Bloomberg
Johnson & Johnson agreed to buy the cancer treatment biotech Halda Therapeutics in a $3.05 billion cash deal, the companies said in a statement Monday. https://t.co/zaDJ9vkfHf ...
Johnson & Johnson agreed to buy the cancer treatment biotech Halda Therapeutics in a $3.05 billion cash deal, the companies said in a statement Monday. https://t.co/zaDJ9vkfHf ...